Longboard Asset Management »

Theravance Biopharma shares owned by Longboard Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Longboard Asset Management from 13F filings

Historical chart of Longboard Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Longboard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Longboard Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $191k 13k 14.60

More positions owned by Longboard Asset Management

Bank of New York Mellon Corporation Common Stocks (BK)
TJX Companies Common Stocks (TJX)
Starwood Property Trust Reit (STWD)
Casey's General Stores Common Stocks (CASY)
Allegion Common Stocks (ALLE)
NewMarket Corporation Common Stocks (NEU)
Itt Common Stocks (ITT)
Rithm Capital Corporation Reit (RITM)
Armstrong World Industries Common Stocks (AWI)
NiSource Common Stocks (NI)
Phillips Edison & Company Reit (PECO)
Monster Beverage Corporation Common Stocks (MNST)
Westinghouse Air Brake Technologies Corporation Common Stocks (WAB)
Altria Group Common Stocks (MO)
Goldman Sachs Group Common Stocks (GS)

View all positions for Longboard Asset Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Oasis Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Morgan Stanley

View all funds holding Theravance Biopharma